Differentiation between dysplastic nodule and early-stage hepatocellular carcinoma: The utility of conventional MR imaging

World Journal of Gastroenterology

Volumn 19, Issue 42, 2013, Pages 7433-7439

  Chou, Chen Te ^a,b   Chou, Jung Mao ^c   Chang, Ting An ^c   Huang, Shiu Feng ^c   Chen, Chia Bang ^b   Chen, Yao Li ^b   Chen, Ran Chou ^c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^c TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

Dysplastic nodule; Hepatocellular carcinoma; Histological grading; Magnetic resonance imaging; Well differentiated hepatocellular carcinoma

Indexed keywords

GADODIAMIDE; GADOLINIUM;

ADULT; AGED; ARTICLE; CANCER STAGING; CHILD PUGH SCORE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; RETROSPECTIVE STUDY;

DYSPLASTIC NODULE; HEPATOCELLULAR CARCINOMA; HISTOLOGICAL GRADING; MAGNETIC RESONANCE IMAGING; WELL-DIFFERENTIATED HEPATOCELLULAR CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; EARLY DETECTION OF CANCER; FEMALE; GADOLINIUM DTPA; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84887577748     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i42.7433     Document Type: Article

References (34)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108 [PMID: 15761078 DOI: 10.3322/canjclin.55.2.74]
2. Donato F, Tagger A, Chiesa R, Ribero ML, Tomasoni V, Fasola M, Gelatti U, Portera G, Boffetta P, Nardi G. Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case-control study in Italy. Brescia HCC Study. Hepatology 1997; 26: 579-584 [PMID: 9303486 DOI: 10.1002/ hep.510260308]
3. Kudo M. Multistep human hepatocarcinogenesis: correlation of imaging with pathology. J Gastroenterol 2009; 44 Suppl 19: 112-118 [PMID: 19148804 DOI: 10.1007/s00535-008-2274-6]
4. Szklaruk J, Silverman PM, Charnsangavej C. Imaging in the diagnosis, staging, treatment, and surveillance of hepatocellular carcinoma. AJR Am J Roentgenol 2003; 180: 441-454 [PMID: 12540450 DOI: 10.2214/ajr.180.2.1800441]
5. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020-1022 [PMID: 21374666 DOI: 10.1002/hep.24199]
6. Yoon SH, Lee JM, So YH, Hong SH, Kim SJ, Han JK, Choi BI. Multiphasic MDCT enhancement pattern of hepatocellular carcinoma smaller than 3 cm in diameter: tumor size and cellular differentiation. AJR Am J Roentgenol 2009; 193: W482-W489 [PMID: 19933622 DOI: 10.2214/AJR.08.1818]
7. Li CS, Chen RC, Tu HY, Shih LS, Zhang TA, Lii JM, Chen WT, Duh SJ, Chiang LC. Imaging well-differentiated hepatocellular carcinoma with dynamic triple-phase helical computed tomography. Br J Radiol 2006; 79: 659-665 [PMID: 16641423 DOI: 10.1259/bjr/12699987]
8. Kudo M. The 2008 Okuda lecture: Management of hepatocellular carcinoma: from surveillance to molecular targeted therapy. J Gastroenterol Hepatol 2010; 25: 439-452 [PMID: 20370723 DOI: 10.1111/j.1440-1746.2009.06207.x]
9. Okada M, Imai Y, Kim T, Kogita S, Takamura M, Kumano S, Onishi H, Hori M, Fukuda K, Hayashi N, Wakasa K, Sakamoto M, Murakami T. Comparison of enhancement patterns of histologically confirmed hepatocellular carcinoma between gadoxetate- and ferucarbotran-enhanced magnetic resonance imaging. J Magn Reson Imaging 2010; 32: 903-913 [PMID: 20882621 DOI: 10.1002/jmri.22333]
10. Kogita S, Imai Y, Okada M, Kim T, Onishi H, Takamura M, Fukuda K, Igura T, Sawai Y, Morimoto O, Hori M, Nagano H, Wakasa K, Hayashi N, Murakami T. Gd-EOB-DTPAenhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow. Eur Radiol 2010; 20: 2405-2413 [PMID: 20490505 DOI: 10.1007/s00330-010-1812-9]
11. Lee MH, Kim SH, Park MJ, Park CK, Rhim H. Gadoxetic acid- enhanced hepatobiliary phase MRI and high-b-value diffusion- weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease. AJR Am J Roentgenol 2011; 197: W868-W875 [PMID: 22021534 DOI: 10.2214/AJR.10.6237]
12. Lee JM, Choi BI. Hepatocellular nodules in liver cirrhosis: MR evaluation. Abdom Imaging 2011; 36: 282-289 [PMID: 21399975 DOI: 10.1007/s00261-011-9692-2]
13. Willatt JM, Hussain HK, Adusumilli S, Marrero JA. MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Radiology 2008; 247: 311-330 [PMID: 18430871 DOI: 10.1148/radiol.2472061331]
14. Roskams T, Kojiro M. Pathology of early hepatocellular carcinoma: conventional and molecular diagnosis. Semin Liver Dis 2010; 30: 17-25 [PMID: 20175030 DOI: 10.1055/ s-0030-1247129]
15. Hytiroglou P, Park YN, Krinsky G, Theise ND. Hepatic precancerous lesions and small hepatocellular carcinoma. Gastroenterol Clin North Am 2007; 36: 867-87, vii [PMID: 17996795 DOI: 10.1016/j.gtc.2007.08.010]
16. Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954; 7: 462-503 [PMID: 13160935 DOI: 10.1002/1097-0142(195405)7]
17. Hamilton SR, Aaltonen LA. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System. Lyon, France: IARC Press, 2000: 159-172
18. Landis JR, Koch GG. The measurement of observer agree-ment for categorical data. Biometrics 1977; 33: 159-174 [PMID: 843571 DOI: 10.2307/2529310]
19. Coleman WB. Mechanisms of human hepatocarcinogenesis. Curr Mol Med 2003; 3: 573-588 [PMID: 14527088 DOI: 10.2174 /1566524033479546]
20. Efremidis SC, Hytiroglou P. The multistep process of hepatocarcinogenesis in cirrhosis with imaging correlation. Eur Radiol 2002; 12: 753-764 [PMID: 11960222 DOI: 10.1007/ s00330-001-1142-z]
21. Jang HJ, Kim TK, Burns PN, Wilson SR. Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation. Radiology 2007; 244: 898-906 [PMID: 17709836 DOI: 10.1148/radiol. 2443061520]
22. Saitoh S, Ikeda K, Koida I, Tsubota A, Arase Y, Chayama K, Kumada H. Serial hemodynamic measurements in welldifferentiated hepatocellular carcinomas. Hepatology 1995; 21: 1530-1534 [PMID: 7768496 DOI: 10.1016/0270-9139(95)90455- 7]
23. Arita J, Hasegawa K, Takahashi M, Hata S, Shindoh J, Sugawara Y, Kokudo N. Correlation between contrast-enhanced intraoperative ultrasound using Sonazoid and histologic grade of resected hepatocellular carcinoma. AJR Am J Roentgenol 2011; 196: 1314-1321 [PMID: 21606294 DOI: 10.2214/ AJR.10.4310]
24. Nakashima Y, Nakashima O, Hsia CC, Kojiro M, Tabor E. Vascularization of small hepatocellular carcinomas: correlation with differentiation. Liver 1999; 19: 12-18 [PMID: 9928760 DOI: 10.1111/j.1478-3231.1999.tb00003.x]
25. Kojiro M. Focus on dysplastic nodules and early hepatocellular carcinoma: an Eastern point of view. Liver Transpl 2004; 10: S3-S8 [PMID: 14762831 DOI: 10.1002/lt.20042]
26. Kim SH, Lim HK, Choi D, Lee WJ, Kim SH, Kim MJ, Kim CK, Jeon YH, Lee JM, Rhim H. Percutaneous radiofrequency ablation of hepatocellular carcinoma: effect of histologic grade on therapeutic results. AJR Am J Roentgenol 2006; 186: S327-S333 [PMID: 16632696 DOI: 10.2214/AJR.05.0350]
27. Ouedraogo W, Tran-Van Nhieu J, Baranes L, Lin SJ, Decaens T, Laurent A, Djabbari M, Pigneur F, Duvoux C, Kobeiter H, Deux JF, Rahmouni A, Luciani A. [Evaluation of noninvasive diagnostic criteria for hepatocellular carcinoma on pretransplant MRI (2010): correlation between MR imaging features and histological features on liver specimen]. J Radiol 2011; 92: 688-700 [PMID: 21819911 DOI: 10.1016/j.jradio.2011.03.020]
28. Shinmura R, Matsui O, Kobayashi S, Terayama N, Sanada J, Ueda K, Gabata T, Kadoya M, Miyayama S. Cirrhotic nodules: association between MR imaging signal intensity and intranodular blood supply. Radiology 2005; 237: 512-519 [PMID: 16244260 DOI: 10.1148/radiol.2372041389]
29. Efremidis SC, Hytiroglou P, Matsui O. Enhancement patterns and signal-intensity characteristics of small hepatocellular carcinoma in cirrhosis: pathologic basis and diagnostic challenges. Eur Radiol 2007; 17: 2969-2982 [PMID: 17618439 DOI: 10.1007/s00330-007-0705-z]
30. Matsui O, Kadoya M, Kameyama T, Yoshikawa J, Arai K, Gabata T, Takashima T, Nakanuma Y, Terada T, Ida M. Adenomatous hyperplastic nodules in the cirrhotic liver: differentiation from hepatocellular carcinoma with MR imaging. Radiology 1989; 173: 123-126 [PMID: 2550995]
31. van den Bos IC, Hussain SM, Terkivatan T, Zondervan PE, de Man RA. Stepwise carcinogenesis of hepatocellular carcinoma in the cirrhotic liver: demonstration on serial MR imaging. J Magn Reson Imaging 2006; 24: 1071-1080 [PMID: 17024654 DOI: 10.1002/jmri.20701]
32. Nicolau C, Vilana R, Bianchi L, Brú C. Early-stage hepatocellular carcinoma: the high accuracy of real-time contrastenhanced ultrasonography in the assessment of response to percutaneous treatment. Eur Radiol 2007; 17 Suppl 6: F80-F88 [PMID: 18376461]
33. Giorgio A, Calisti G, di Sarno A, Farella N, de Stefano G, Scognamiglio U, Giorgio V. Characterization of dysplastic nodules, early hepatocellular carcinoma and progressed hepatocellular carcinoma in cirrhosis with contrast-enhanced ultrasound. Anticancer Res 2011; 31: 3977-3982 [PMID: 22110230]
34. Kudo M. Diagnostic imaging of hepatocellular carcinoma: recent progress. Oncology 2011; 81 Suppl 1: 73-85 [PMID: 22212940 DOI: 10.1159/000333265]